Visualitza per autor "Colombo, Nicoletta"
Ara mostrant els elements 1-6 d 6
-
Maintenance treatment with rucaparib for recurrent ovarian carcinoma in ARIEL3, a randomized phase 3 trial: The effects of best response to last platinum-based regimen and disease at baseline on efficacy and safety
Oaknin Benzaquen, Ana Mazaltob; Oza, Amit M.; Lorusso, Domenica; Aghajanian, Carol; Dean, Andrew; Colombo, Nicoletta (Wiley, 2021-10) -
Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1/BRCA2 mutation: OPINION primary analysis
Poveda, Andres; Lheureux, S.; Colombo, Nicoletta; Cibula, David; Lindemann, Kristina; Weberpals, J.; Oaknin Benzaquen, Ana Mazaltob (Elsevier, 2022-03) -
Patient-Centered Outcomes in ARIEL3, a Phase III, Randomized, Placebo-Controlled Trial of Rucaparib Maintenance Treatment in Patients With Recurrent Ovarian Carcinoma
Oza, Amit M.; Lorusso, Domenica; Aghajanian, Carol; Oaknin Benzaquen, Ana Mazaltob; Dean, Andrew; Colombo, Nicoletta (American Society of Clinical Oncology, 2020-10-20) -
Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I
Moore, Kathleen N; Oza, Amit M.; Colombo, Nicoletta; Oaknin Benzaquen, Ana Mazaltob; Scambia, Giovanni; Lorusso, Domenica (Elsevier, 2021-06) -
The effect of age on efficacy, safety and patient-centered outcomes with rucaparib: A post hoc exploratory analysis of ARIEL3, a phase 3, randomized, maintenance study in patients with recurrent ovarian carcinoma
Colombo, Nicoletta; Oza, Amit M.; Lorusso, Domenica; Aghajanian, Carol; Oaknin Benzaquen, Ana Mazaltob; Dean, Andrew (Elsevier, 2020-10-01) -
Tolerability of maintenance olaparib in newly diagnosed patients with advanced ovarian cancer and a BRCA mutation in the randomized phase III SOLO1 trial
Colombo, Nicoletta; Moore, Kathleen N; Scambia, Giovanni; Oaknin Benzaquen, Ana Mazaltob; Friedlander, Michael; Lisyanskaya, Alla (Elsevier, 2021-10)